The population of brain pericytes, a cell type important for vessel stability and blood brain barrier function, has recently been shown altered in patients with Alzheimer's disease (AD). The underlying reason for this alteration is not fully understood, but progressive accumulation of the AD characteristic peptide amyloid-beta (Ab) has been suggested as a potential culprit. In the current study, we show reduced number of hippocampal NG2+ pericytes and an association between NG2+ pericyte numbers and Ab1-40 levels in AD patients. We further demonstrate, using in vitro studies, an aggregation-dependent impact of Ab1-40 on human NG2+ pericytes.
between pericyte number and Ab load has been found in transgenic APP mouse, an in vivo model of AD (Winkler, Sagare & Zlokovic, 2014) . Secondly, in vitro studies show that Ab influences survival of cultured brain pericytes. However, it is important to point out that Ab can appear in several different species, whereof are two of the most abundant forms. Alzheimer 0 s disease is foremost associated with the former specie, as insoluble Ab1-42 fibrils are the major component of Ab plaques and soluble oligomer Ab1-42 is strongly neurotoxic (Dahlgren et al., 2002) . The impact of Ab1-42 on brain pericytes in the human brain is scarcely investigated, but a few in vitro studies show reduced cell survival after prolonged Ab1-42 stimulation (Verbeek, de Waal, Schipper & Van Nostrand, 1997; Wilhelmus et al., 2007) and altered shedding of the pericyte adhesion molecule chondroitin sulphate proteoglycan NG2 in the presence of oligomer and fibril Ab1-42 (Schultz, Nielsen, Minthon & Wennstrom, 2014) . In comparison with Ab1-42, Ab1-40 has in several human brain tissue studies been shown to have an impact on pericytes. This Ab specie is not as prone to aggregate as Ab1-42, but can nonetheless form depositions, so-called cerebral amyloid angiopathy (CAA), in the vessel walls in the brain (Maia, Mackenzie & Feldman, 2007) . The CAA is often associated with pericytes displaying degenerative features (Verbeek, Van Nostrand, Otte-Holler, Wesseling & De Waal, 2000) , and thus, it has been hypothesized that aggregated Ab1-40 is particularly toxic for pericytes. Studies showing a reduced cell survival of cultured human brain pericytes in presence of Dutch variant of Ab1-40 (a mutation promoting aggregation) support this hypothesis (Verbeek et al., 1997) .
To conclude, several clinical and preclinical studies show that Ab influences the pericyte population, but whether either of the Ab species (i.e. Ab1-40 or Ab1-42) and whether aggregation forms of the Ab species play a role in the pericyte loss seen in AD patients remain to be investigated. We therefore analysed the pericyte population in AD patients, in comparison with nondemented controls, by staining postmortem brain tissue against NG2 and laminin alpha (a)5. These two markers are found on different subset of pericytes: NG2 is expressed by activated pericytes on arterioles/capillaries (Stapor, Sweat, Dashti, Betancourt & Murfee, 2014) and laminin is expressed by mature pericytes on arterioles and capillaries as well as postcapillary venules (Yousif, Di Russo & Sorokin, 2013) . The association between pericyte numbers and levels of Ab1-40 or Ab1-42 in brain homogenates was thereafter analysed. We also investigated the direct impact of different aggregations forms of Ab1-40 and Ab1-42 on proliferation, cell survival and caspase 3/7 activity of cultured human brain pericytes. Figure 1h . We also investigated whether APOE-e4 genotype affects the measured pericyte variables, but we found no differences in either NG2+ or laminin+ pericyte numbers, vessel length or number of pericytes/vessel length when comparing APOE-e4 carriers (n = 13) with APOE-e4 noncarriers (n = 12). Finally, we found no association between age and any of the measured pericyte variables and no difference in pericyte variables when males were compared with females or when patients with severe vascular disease where compared with patients without severe vascular disease.
| Correlations between Ab1-40 levels and number of pericytes and number of pericytes/vessel in AD patients
Next, we investigated whether levels of Ab1-40 and Ab1-42 in the hippocampal samples were associated with the pericyte loss in AD patients. We therefore dissolved PFA-fixed brain sections in formic acid and measured the total amount of Ab levels (aggregated + soluble Ab). We found a trend towards higher levels of Ab1-42 and higher Ab1-42/40 ratio in the AD patients compared to nondemented controls (17.91 AE 19.59 vs. 4.64 AE 11.91, p = .061 and 7.39 AE 10.78 vs. 0.78 AE 1.46, p = .058, respectively) . In contrast, levels of Ab1-40 were not significantly different when the two groups were compared (10.10 AE 12.31 vs. 5.10 AE 4.98, p = .209).
Correlation analysis further showed that levels of Ab1-40 and number of NG2+ pericytes significantly correlated when the whole cohort was analysed (r = .470, p = .024). This correlation remained significant when the AD patient group was separately analysed (r = .713, p = .014; Figure 2a ), but only a trend to significance was seen when the nondemented control group was analysed (r = .504, p = .095). We also found a positive correlation between Ab1-40 levels and the number of NG2+ pericytes/vessel length in AD patients (r = .705, p = .015) (Figure 2b ), but a similar association was not found in nondemented controls. Finally, when the whole cohort was analysed, we could see a negative and significant correlation between the Ab1-42/40 ratio and the NG2+ number of pericytes (r = À0.451, p = .035) as well as between Ab1-42/40 ratio and the number of NG2+ pericytes/vessel length (r = À0.544, p = .009). This correlation was lost when the analysis was performed on the AD and NC groups separately. No significant correlations were found between the brain Ab1-42 levels and any of the NG2+ pericyte variables (i.e. the number of pericytes, the length of the vessels and the number of pericytes/vessel), regardless of whether the whole cohort was analysed or the two groups were analysed separately ( Figure S1 ).
No correlations between Ab1-40, Ab1-42 or Ab1-42/40 ratio and any of the laminin+ pericyte variables were found, regardless of whether the whole cohort was analysed or the two groups were analysed separately. Furthermore, we found no correlation between the measured NG2+ or laminin+ pericyte variables and ABC amyloid stages or Braak stages for NFT.
| Cell culture studies
Since our postmortem studies indicate that Ab1-40 levels are associated with changes in NG2+ pericytes numbers in the AD brain, we found it interesting to investigate the direct impact of different aggregation forms of Ab1-40 on brain pericyte population. For this purpose, we used NG2-and PDGFR-b-expressing HBVP as a cell culture model of brain pericytes and analysed alterations in viability, caspase activity and proliferation of these cells after exposure to different aggregation forms of Ab1-40 and Ab1-42. Analysis of both Ab preparations used in the experiment showed that the fibrilenriched preparations (EP) contained higher amount of thioflavin T (ThT)-incorporated b-sheets (indicative of fibril formation) compared to oligomer-EP and monomer preparation. The amount of oligomers (detected with oligomer-specific antibody ELISA) was higher in the Ab1-40 oligomer-EP compared to monomer and fibril-EP, whereas the Ab1-42 oligomer-EP and the Ab1-42 fibril-EP contained equally higher amount of oligomers compared monomer preparations (Figure S3 | 3 of 13 approximately 100nm and above, whereas the oligomer preparations contained primarily oligomers ( Figure S4 (Stapor et al., 2014) , but laminin a5 is additionally expressed by pericytes on postcapillary venules (Yousif et al., 2013) . Importantly, pericytes are dynamic and versatile and the expression of markers, which includes also nestin, desmin, CD13, PDGFR-ß and RGS5, fluctuates depending on activation, migration and vessel-stabilization pericyte state. For example, NG2 is associated with both mature and active pericytes (migration, vascular remodelling and inflammation; Stapor et al., 2014) , whereas pericytes expressing laminin are foremost found on quiescent and mature vessels (Hallmann et al., 2005) . None of the markers mentioned above are found on all pericytes, and hence, immunohistochemistry based on one marker only enables analysis of a subset of the pericyte population. Our study showed significantly decreased number of NG2+
pericytes as well as decreased number of NG2+ pericytes/vessel length in AD patients compared to nondemented controls, but the analysis of laminin+ pericytes showed no significant differences in pericyte variables between the groups. This difference highlights the heterogeneity of the pericyte population (i.e. marker expression and localization) and proposes an impact of AD pathology on foremost activated pericytes. The reduction in NG2+ pericytes could be due to a direct impact on the pericyte population either by degeneration or formation of new NG2+ pericytes, but in view of our laminin result we cannot exclude the possibility that the pericyte population size remains the same and the difference is due to a downregulation of NG2 expression. Nevertheless, the results found in our study are in line with the previous study by Sengillo and colleagues, demonstrating a pericyte loss in AD patients (Sengillo et al., 2013) . In that study, the number of mural cells (an umbrella term for smooth muscle cells and pericytes) was analysed by measuring the amount of PDGFR-b+ (a marker for migrating immature mural cells (Song, Ewald, Stallcup, Werb & Bergers, 2005) ) and CD13+ (marker for activated pericytes (Svensson, Ozen, Genove, Paul & Bengzon, 2015) ) cells associated with vessels/capillaries in hippocampus. They found a 60% reduction in hippocampal mural cells and a 33% reduction in hippocampal pericytes, which is in the order of magnitude with our own study (approximately 26% reduction in NG2+ pericytes). In view of these findings, we conclude that different subsets of pericytes involved in migration, activation and remodelling (NG2+, PDGFR-b+ and CD13+ pericytes) are affected by AD pathology, whereas mature and quiescent pericytes (laminin+) are less affected.
As mentioned in the introduction, previous studies have suggested Ab, in particular Ab1-40, to be toxic for pericytes (Verbeek et al., 1997; Wisniewski, Wegiel, Wang & Lach, 1992) . We therefore aggregated Ab1-40 in the samples before FA treatment. Since aggregated Ab1-40 has been shown to be toxic (Maia et al., 2007) and monomer is potentially beneficial (as described in our in vitro studies), we speculate that samples from AD patients with lower number of NG2+ pericytes also contain higher portions of toxic aggregated Also, fibril morphology and distribution have been used to distinguish the different forms, where individually dispersed fibrils with a curvilinear feature have been defined as protofibrils (Hartley et al., 1999; O'Nuallain et al., 2010; Paranjape, Gouwens, Osborn & Nichols, 2012; Relini et al., 2010) . Our fibril preparations contained straight, aggregated fibrils, which were approximately 100 nm and above. In addition, our OMAB and ThT analysis demonstrated lower amount of oligomer and higher amount of b-sheets in fibril-EP compared to oligomer-EP. We therefore draw the conclusion that our fibril-EP contains high amounts of fibrils, but due to the length of our fibrils, we cannot exclude the possibility that a portion of those fibrils are protofibrils.
Our results further showed that the HBVP viability, 3/7 activity and proliferation were not affected by the oligomer form of Ab1-40.
This is particularly interesting since the oligomer form of Ab1-42, and not the fibril form of this specie, is regarded as the most toxic form (Benilova, Karran & De Strooper, 2012) . Our own comparative study showed that stimulation with both oligomer-EP Ab1-42 and fibril-EP Ab1-42 decreased HBVP viability measured by LDH. This result should be viewed from the fact that Ab1-42 is more prone than Ab1-40 to form alternative structures in the path towards a fibril. This feature results in more heterogeneous preparations and analysis of our preparations revealed the presence of oligomers in both oligomer-EP and fibril-EP Ab1-42 preparations, whereas fibrils were only found in the fibril-EP Ab1-42 preparation. We are therefore unable to unambiguously show the impact of Ab1-42 fibrils on HBVP viability, but the increased cell death seen in response to oligomer-EP Ab1-42 exposure is in line with previous studies (Benilova et al., 2012) , highlighting the different impact of the two Ab species in regard to oligomer toxicity.
In contrast to fibril-EP Ab1-40, our in vitro results showed that monomer Ab1-40 both had a rescuing and mitogenic impact on HBVPs. Similar beneficial effect of Ab1-40 has been described before. For example, Ab1-40 prevents degradation of cell membrane lipids by inhibiting auto-oxidation of CSF and plasma lipoproteins (Kontush et al., 2001) , an event known to be increased in AD patients (Bassett et al., 1999) . The Ab1-40 peptide is further the most effective Ab specie to rescue cultured neurons which are dying in response to endogenous Ab inhibition (Plant, Boyle, Smith, Peers & Pearson, 2003) . Our own cell viability results, showing decreased cell death as well as decreased caspase 3/7 activity after monomer Ab1-40 exposure, support the idea that Ab1-40 is beneficial for cell survival. But our results also show that it is foremost the monomers that have this ability. Apparently, the Ab1-40 monomers also have a strong mitogenic impact on HBVPs as our proliferation assay showed marked increased cell division in response to the stimulus. This finding is backed up by a previous study demonstrating a mitogenic property of monomer Ab1-40 on cultured human skin fibroblasts (Theda, Drews, Zitnik, Oshima & Martin, 2016) , a cell type sharing both origin and certain markers with the pericyte (Birbrair et al., 2013) . Interestingly, decreased caspase activity has been associated with hyperproliferation of pancreatic b-cells in mice (Woo et al., 2003) . It may thus be that the decreased activity of caspase 3/7 in SCHULTZ ET AL.
| 7 of 13 response to monomer Ab1-40 seen in our study contributes to both the increased cell viability and the increased cell division. Finally, it is important to point out that cell cultures can never replicate a biological system and although pericyte proliferation does occur in the human brain (Fernandez-Klett et al., 2013; Goritz et al., 2011; Matsushita et al., 2015; Paul et al., 2012) , the conditions and rate in the brain are not comparable to the same in a Petri dish. Hence, we would like to stress that our cell model is useful foremost as a tool to demonstrate that differences in pericyte response to Ab depend on both aggregation form and specie.
| CONCLUSIONS
To conclude, our results confirm the previous study demonstrating pericyte alterations in AD patients and highlight Ab1-40 as a potential regulator of brain pericyte population. Moreover, our in vitro studies
show that the regulatory role of Ab1-40 is dependent on aggregation form, where the monomeric appears to have a rescuing and mitogenic impact, oligomers are quiescent and fibrils induce toxicity. This is particularly interesting given the common notion that the oligomer form of the kin peptide, Ab1-42, is considered to be the culprit behind neuronal loss in AD. Hence, our results point out the differences between Ab species and their aggregation forms in terms of toxicity on pericytes, a finding important to take into consideration when targeting the aggregation process of Ab as a treatment for AD.
| EXPE RIMENTAL PROCEDURES

| Individuals included in the study
The study includes frozen samples of midlevel hippocampus from clinically and postmortem-verified patients with AD (n = 13) and nondemented controls (n = 9) (Netherlands Brain Bank (NBB)).
Neuropathological assessments were performed by NBB according to Braak stages of neurofibrillary tangles (NFT) spreading (Braak & Braak, 1995) and Lewy bodies (LB) (Braak et al., 2003) and ABC staging for amyloid (Ab) (Schultz, Hubbard, Rub, Braak & Braak, 2000) . Individuals which after clinical evaluation were considered nondemented and after neuropathological NFT evaluation were scored as 3 or less were considered as nondemented controls. None of the patients included in the study displayed CAA or LB pathology in hippocampus. Individuals with hypertension in combination with either of the following criteria (i) transient ischaemic attack/stroke, (ii) valvular heart disease, (iii) ischaemic heart disease or (iv) arrhythmias were considered as severe cardiovascular disease (CVD) patients. Single nucleotide polymorphisms at positions rs429358 and rs7412 of the APOE gene were determined by polymerase chain reactions using allele-specific primers. Demographic data and the neuropathological assessment of the individuals are presented in Toetsingscommissie (METc) of VU University has approved the procedures of brain tissue collection, and the regional ethical review board in Lund has approved the study.
| Immunostaining procedures of brain tissue
The frozen hippocampal samples were fixed in 4% paraformaldehyde (PFA) for 4 hr and left in phosphate-buffered saline (PBS) containing 30% sucrose until they were sunken. The tissue was then cut into 40-lm-thick sections using a Microtome Leica and stored free floating in antifreeze cryoprotectant solution at À20°C until analysis. In order to examine the number of pericytes, the brain sections were immunohistochemically (IHC) stained against either the pericyte marker NG2
(which clearly reveals pericyte cell bodies and the whole length of vessels) or laminin a5 (which is expressed by both pericytes and endothelial cells (Yousif et al., 2013) to cell experiments, fibril-and oligomer-enriched preparations (EP) of Ab1-40 and Ab1-42 were generated according to previously published protocol (Brannstrom et al., 2014) . The Ab1-40 and the Ab1-42 peptides were solubilized in 10 mM NaOH pH 11, and then the pH was adjusted to pH 7.0 by further diluting the solution to a concentration of 100 lM in phosphate buffer. Fibril-EP was generated by a 72-hr incubation with agitation in 37°C and oligomer-EP was generated by 20-min incubation with agitation RT. Monomer preparations of Ab1-40 and Ab1-42 were generated by dissolving the peptide in DMSO to the concentration of 2.5 mM and then further diluted to a concentration of 100 lM in phosphate buffer. Prior to cell experiments, fibril, oligomer and monomer preparations were generated by diluting to the 100 lM preparations to the working 
| Cell culture treatment
The medium was removed 2 hr prior to experiments and replaced with serum-free medium in order to synchronize the cells. After serum starvation, the medium was once again removed and replaced with either serum-free medium (for the toxicity experiments) or serum-supplemented medium (for the proliferation experiments) containing either 10 lM fibril-EP Ab1-40, 10 lM oligomer-EP Ab1-40, 10 lM monomer Ab1-40, 10 lM fibril-EP Ab1-42, 10 lM oligomer-EP Ab1-42, 10 lM monomer Ab1-42 or their respective controls, that is vehicle used for oligomer-and fibril-EP Ab1-40 and Ab1-42 (NaOH/ PBS) or vehicle used for monomer Ab1-40 and Ab1-42 (DMSO/ PBS). These controls will be referred to as Ctrl O/F and Ctrl M, respectively. All experiments were performed in duplicate and repeated independently three times. The cells were incubated in 37°C for 24 or 96 hr depending on the assay. Cell culture supernatant was collected after treatment, centrifuged (275 9 g 5 min, 4°C), aliquoted and stored at À80°C until used. Cells were lysed using cell lysis kit (Sigma-Aldrich), aliquoted and stored at À80°C until used.
| Analysis of cytotoxicity
To evaluate cytotoxic effect, we used two different cytotoxicity assays (i) extracellular lactate dehydrogenase activity (LDH) (measures foremost necrosis) and (ii) caspase 3/7 activity (measures foremost apoptosis). The levels of LDH activity were measured in conditioned medium using LDH assay kit (Sigma-Aldrich). In 96-well plates (Nunc), 100 ll HBVPs cell-free supernatants were mixed with 100 ll reagent buffer, agitated 30 s 300-450 rpm and then incubated 30 min at RT. The absorbance was measured at 490 nm using Microplate Spectrophotometer Infinite M200 and the Magellan version 3.5 software. Caspase 3/7 activity was analysed using CaspaseGlo 3/7 luminescence assay according to the manufacturer's instructions (Promega, Fitchburg, WI). 
| Proliferation analysis
| Statistical analysis
Statistical analysis was performed using SPSS software (version 24
for Mac, SPSS Inc., Chicago, IL). The Kolmogorov-Smirnov test was used to assess normal distribution. Since number of pericytes, vessel length and the ratio of pericytes/vessel length were normally distributed, differences between diagnose groups were analysed by the use of independent-samples t-test. Levels of Ab1-40 and Ab1-42 as well as Ab1-42/40 ratio were not normally distributed, and thus, Mann-Whitney U-test was used when comparison analysis of these values was performed. Consequently, correlations between the investigated variables in the brain study were examined using the Spearman correlation test. Differences between Ctrl O/F and oligomer-and fibril-EP in the in vitro study were analysed using one-way analysis of variance (ANOVA), followed by Dunnett's post hoc correction (comparisons for n = 4), whereas the comparisons between monomer preparations of Ab1-40 and Ab1-42 and their control were analysed using Student's t-test. Results are presented as means AE standard deviations, and a value of p < .05 level was considered statistically significant. advising on the approach of the study; MW designed the study and edited the final version of the manuscript. All authors read and approved the final manuscript.
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